Pricing Log in Create free account
Friday 6 November 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.

Revenue
+4.13%
EPS
−21.7%
Free cash flow
−63.7%

Quarter to September 2026, against a year earlier

564.88 43.61 −7.17%
Market cap
$24.3B
P/E
19.7×
Fwd P/E
22.5×
Dividend yield
—
F-score
8/9
Altman Z
19.55
Beneish M
−2.26
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

United Therapeutics Corporation (UTHR) Current ratio

Alert me on Current ratio

United Therapeutics Corporation's current ratio at the end of the quarter to 30 September 2026 was 4.7×, down 1.9× from fiscal 2025 (6.6×). Over the past ten years it has ranged from 2.9× (fiscal 2015) to 9.8× (fiscal 2022); the current reading is higher than 73% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.4× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 6.6× 25.84%
FY2024 5.2× 18.89%
FY2023 4.4× (55.18%)
FY2022 9.8× 29.45%
FY2021 7.6× 13.50%
FY2020 6.7× 66.46%
FY2019 4.0× (37.00%)
FY2018 6.4× 96.32%
FY2017 3.3× (24.02%)
FY2016 4.3× 48.08%

Quarterly newest first

Period Current ratio Change
Sep 2026 4.7× (18.63%)
Jun 2026 5.7× 19.56%
Mar 2026 4.8× (27.41%)
Dec 2025 6.6× 3.26%
43 more quarters

Against its own ten years

Low 2.9× High 9.8×
Ten-year median 5.2×
Current reading's percentile 73

Current ratio against peers

Company Current ratio
UTHR United Therapeutics Corporation 4.7×
ZTS Zoetis Inc. compare 3.1×
ELAN Elanco Animal Health Incorporated compare 2.1×
NBIX Neurocrine Biosciences, Inc. compare 2.0×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
VTRS Viatris Inc. compare 1.6×
TAK Takeda Pharmaceutical Co. compare 1.2×
TEVA Teva Pharmaceutical Industries Ltd. compare 0.9×
HLN Haleon PLC Sponsored ADR compare 0.7×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on UTHR